Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) [Yahoo! Finance]
HilleVax, Inc. (HLVX)
Company Research
Source: Yahoo! Finance
has been part of a series of sales by the insider over the past year, with a total of 50,866 shares sold and no shares purchased during this period. Warning! GuruFocus has detected 3 Warning Sign with HLVX. HilleVax Inc ( NASDAQ:HLVX ) is a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates. The company's primary aim is to address unmet medical needs in the prevention of diseases with significant impact on public health. The insider transaction history at HilleVax Inc ( NASDAQ:HLVX ) indicates a trend of insider sales, with 11 recorded over the past year and no insider buys during the same timeframe. This pattern of insider activity can often provide insights into the company's performance and insider perspectives on the stock's valuation. On the date of the insider's recent sale, shares of HilleVax Inc ( NASDAQ:HLVX ) were trading at $18.66, giving the company a market capitalization of $892.21 million. Investors and analy
Show less
Read more
Impact Snapshot
Event Time:
HLVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLVX alerts
High impacting HilleVax, Inc. news events
Weekly update
A roundup of the hottest topics
HLVX
News
- HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation [Seeking Alpha]Seeking Alpha
- HilleVax, Inc. (NASDAQ: HLVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.MarketBeat
- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]Yahoo! Finance
- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressGlobeNewswire
- Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) [Yahoo! Finance]Yahoo! Finance
HLVX
Earnings
- 3/20/24 - Beat
HLVX
Analyst Actions
- 3/21/24 - HC Wainwright
HLVX
Sec Filings
- 5/3/24 - Form 4
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- HLVX's page on the SEC website